Tag Archives: biomarkers

Rayno Life Science: Tools and Diagnostics Q1 2014 Performance

Caution As Life Science Stocks Are Consolidating Life science stocks had a wild roller coaster ride in 2014 with many stocks peaking around March 1. Momentum and cult stocks in our portfolio still had a good quarter with the following top winners: Illumina (ILMN) up 25.2%, Vermillion (VRML) up 25%, Exact Sciences (EXAS) up 21% […]

Leave a comment Continue Reading →

Rayno Life Science Stocks Rally On A Choppy Day: ALXN, AMGN, BIIB, PCYC

Mini-Rally in Life Science Stocks— Update 10p PDT Biotech stocks recovered off their am lows today with major ETFs  (FBT,IBB,XBI ($161.45) up about 0.3% and within 5% of highs. Over the past week or so biopharma stocks have been weak with a “topping” process evident in late February.  Volatility has increased with daily swings and some mid-cap […]

Comments Off Continue Reading →

Rayno Dx and Tools Stocks Up in January: CPHD, ILMN

Molecular Diagnostics and Sequencing Technologies  Are Big Winners in January 2014 But Recent Two Day Sell-Off Has Done Damage To Many Stocks Diagnostic stocks were a sea of red today after a huge January driven by growth expectations from new products and platform molecular technologies. As financial reporting is due for many of these stocks this […]

Comments Off Continue Reading →

Rayno Dx and Tools Picks-2014 YTD Post J.P.Morgan Conference

 2014 J.P. Morgan Conference Update #5-Rayno Diagnostics and Tools Portfolio Amazing start for the New Year Performance among Clinical Diagnostics and Tools stocks was  strong with  many stocks beating the sector indices (IBB) which were up 10-15%. Stock performance in 2014 will be more dependent on earnings and guidance although there is considerable sentiment carry-over […]

Comments Off Continue Reading →

J.P.Morgan Healthcare Conference Update #2: Rayno Life Science Stocks CPHD,ILMN, NSTG,QGEN

Biotech Rally Continues With IBB ($245) At New Highs-Up 10 Pts. From Monday’s Bottom Several Rayno Life Science picks were up after presentations at the 2014 J.P.Morgan Healthcare Conference. All of our portfolio picks are strong holds unless otherwise noted. Our objectives for Rayno Life Science in 2014 will be to: Continue our portfolio approach […]

Comments Off Continue Reading →

Rayno Life Science Focus Stocks Part II-2013 Performance Diagnostics and Tools

New Products for Molecular and Companion Diagnostics Drive Growth Rayno Life Science Big Winners-ALR, CSII, ILMN,TMO A diversified life science portfolio must include clinical diagnostics and tools stocks because of the synergies between therapy and diagnostics. Breakthroughs in molecular diagnostics for personalized medicine, genetic testing and infectious diseases are driving new product cycles for timely, […]

Comments Off Continue Reading →